Evidence map›Paper›PMID 41918111›Full record

ArticleJournal of translational medicine2026

Cross-algorithm machine learning and consensus features for early disseminated intravascular coagulation risk prediction in sepsis-induced coagulopathy.

Fanxuan Chen, Xuewen Mei, Dongren Yang, Darong Hai, Xueying Bao, Hao Chen, Ruoyun Wang, Zefei Mo, Yu Xia, Li Zeng and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Fanxuan Chen *The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Xuewen Mei *Wenzhou Medical University, Wenzhou, 325000, China.
Dongren Yang *The First School of Medicine, School of Information and Engineering, Wenzhou Medical University, Wenzhou, 325001, China.
Darong Hai *School of Nursing, Wenzhou Medical University, Wenzhou, 325000, China.
Xueying Bao *Department of Physics, Research Institute for Biomimetics and Soft Matter, Fujian Provincial Key Laboratory for Soft Functional Materials Research, Xiamen University, Xiamen, 361005, China.
Hao ChenThe First School of Medicine, School of Information and Engineering, Wenzhou Medical University, Wenzhou, 325001, China.
Ruoyun WangThe First School of Medicine, School of Information and Engineering, Wenzhou Medical University, Wenzhou, 325001, China.
Zefei MoWenzhou Medical University, Wenzhou, 325000, China.
Yu XiaThe First School of Medicine, School of Information and Engineering, Wenzhou Medical University, Wenzhou, 325001, China.
Li ZengThe Second Clinical Medical College of Wenzhou Medical University, Wenzhou, 325000, China.
Ziyang ZhangThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Yan ZuWenzhou Medical University, Wenzhou, 325000, China. zuyan@foxmail.com.
Qi ZhaoSchool of Computer Science and Software Engineering, University of Science and Technology Liaoning, Anshan, 114051, China. zhaoqi@lnu.edu.cn.ORCID 0000-0001-9713-1864
Jingye PanKey Laboratory of Intelligent Treatment and Life Support for Critical Diseases of Zhejiang Province, Wenzhou, 325000, China. panjingye@wzhospital.ac.cn.
Xiaowei XuThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China. xiaoweixu2022@foxmail.com.

Funding

Fundamental Research Funds for the Liaoning Universities LJ212410146026National Key Research and Development Program of China 2023YFF0613600National Natural Science Foundation of China 32101057Science and Technology Plan Project of Liaoning Province 2025-MSLH-351WIU- CASQD2022009 of the Wenzhou Institute at University of Chinese Academy of Science CASQD2022009
6 · The paper itself

Abstract

backgroundSepsis-induced coagulopathy (SIC) represents an early and potentially reversible stage of coagulation dysfunction in sepsis, whereas progression to disseminated intravascular coagulation (DIC) is associated with multi-organ failure and markedly increased mortality. Although existing diagnostic criteria and machine learning (ML) models have demonstrated utility in broad sepsis populations, they lack specificity for identifying high-risk subgroups within SIC patients who are most likely to deteriorate into DIC. Timely and precise risk stratification at this critical transition point remains an unmet clinical need.

methodsWe conduct a retrospective, multicenter study integrating data from MIMIC-IV v3.1 database and an independent cohort from the First Affiliated Hospital of Wenzhou Medical University. A total of 4,874 SIC patients are included, comprising 1,629 patients from the local cohort and 3,245 patients from MIMIC-IV. Using 61 routinely available clinical variables collected within 48 h of ICU admission, we design a two-stage ML framework. In phase I, 16 ML algorithms are combined with 11 feature importance ranking methods and backward elimination to identify algorithm-specific optimal feature subsets. In phase II, a cross-algorithm consensus strategy is applied to extract globally stable features and construct a minimalist, interpretable predictive model. Model performance is evaluated using accuracy (ACC), area under the receiver operating characteristic curve (AUC), and F1-score. External validation was performed using the MIMIC-IV cohort. Model interpretability was assessed through permutation feature importance, SHapley Additive exPlanations (SHAP), and a clinically deployable nomogram, with calibration curves and decision curve analysis (DCA) used to assess clinical utility.

resultsAcross single-algorithm optimization, the Gradient Boosting Classifier (GB) model achieved the best balance between performance and robustness. Cross-algorithm consensus analysis identified seven highly stable predictors: intensive care unit (ICU) length of stay (LOS), vasopressor, albumin (ALB) level, Modification of Diet in Renal Disease (MDRD) estimate, Logistic Organ Dysfunction System (LODS) score, Sequential Organ Failure Assessment (SOFA) score, Continuous Renal Replacement Therapy (CRRT). The final GB model incorporating these seven features achieved an F1-score of 0.71 and an AUC of 0.75 in the internal validation cohort, while demonstrating excellent generalization in the external validation cohort (F1-score 0.92, AUC 0.74, ACC 0.92). Interpretability analyses confirmed that disease severity, organ dysfunction, and treatment intensity were the primary drivers of DIC progression. The nomogram exhibited good calibration and provided consistent net clinical benefit across a wide range of risk thresholds in DCA.

conclusionsWe propose a robust and interpretable ML framework for early identification of SIC patients at high risk of progression to DIC, based on only seven routinely available clinical indicators. By transitioning from algorithm-specific optimization to cross-algorithm consensus feature selection, this study achieves a favorable balance between predictive performance, generalizability, and clinical usability. This model offers a practical decision-support tool for precision risk stratification and targeted intervention in sepsis-associated coagulopathy. Prospective multicenter studies incorporating dynamic time-series data are warranted to further validate and extend its real-time clinical applicability.

Indexed as

AlgorithmsBlood Coagulation DisordersConsensusDisseminated Intravascular CoagulationMachine LearningSepsisAgedFemaleHumansMaleMiddle AgedPrediction AlgorithmsPredictive Learning ModelsRisk FactorsROC CurveDisseminated intravascular coagulationInterpretabilityMachine learningSepsis-induced coagulopathyTwo-stage feature selection

Identifiers

PMID41918111
PMCPMC13169860

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.